Evolving Treatment Options for Thrombocytopenic Patients With MDS

Drs. Amy DeZern and Srdan Verstovsek discuss their top abstract choices from ASH 2020 in MDS and MPNs, from Clinical Care Options (CCO)

Amy E. DeZern, MD, MHS Srdan Verstovsek, MD, PhD Released: February 23, 2021

From Clinical Care Options, experts review key data in MDS and MPNs from ASH 2020

Amy E. DeZern, MD, MHS Srdan Verstovsek, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: February 16, 2021 Expired: February 15, 2022

Brief expert video from Clinical Care Options (CCO) on recommended treatment strategies for patients with myelodysplastic syndrome (MDS) and thrombocytopenia

Rami S. Komrokji, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 21, 2021 Expired: January 20, 2022

Brief expert video from Clinical Care Options (CCO) on recommended treatment strategies for anemia in patients with myelodysplastic syndrome (MDS)

Rami S. Komrokji, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 19, 2021 Expired: January 18, 2022